Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call

28 oktober 2013 Oslo, Norway, 28 October 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will announce its third quarter 2013 results on Wednesday, 6 November 2013. A presentation by members of Algeta's executive management team to investors, analysts and the press will take place in Oslo at 10:00 CET. The presentation will also be webcast live and can be accessed through www.algeta.com where questions can also be submitted during the presentation. The presentation will take place at 10:00 CET at: KS-Agenda Møtesenter Haakon VIIs gate 9 0161 Oslo Norway. At 14:30 CET/08:30 Eastern Time, Algeta's executive management team will also host an international conference call. To participate in the conference call, please dial the appropriate number below five minutes prior to the call: US: +1 877 423 0830 UK: +44 20 7153 9154 Norway: +47 21 06 61 13 Sweden: +46 8-506 443 86 Denmark: +45 32 71 42 62 Switzerland: +41 44 580 65 22 Participant pin code: 873878# To access the replay, please dial: US: +1 877 679 2989 UK: +44 203 364 5200 Norway: +47 23 50 02 03 Sweden: +46 8-505 564 73 Conference reference: 348995# A replay of the conference call will also be available at www.algeta.com. The results report and the presentation will be available at www.algeta.com in the Investors section from 07:00 CET. ### For further information, please contact: Mike Booth +1 646 410 1884 Communications & Corporate Affairs ir@algeta.com Media enquiries: Mark Swallow +44 207 638 9571 Citigate Dewe Rogerson mark.swallow@citigatedr.co.uk Knut Ekern +47 22 04 82 00 Gambit Hill & Knowlton knut.ekern@hkstrategies.com Kari Watson +1 781 235 3060 MacDougall Biomedical Communications kwatson@macbiocom.com Investor enquiries: Tricia Truehart +1 646 378 2953 The Trout Group ttruehart@troutgroup.com About Algeta Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Press release: http://hugin.info/134655/R/1738455/583159.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Algeta ASA via Thomson Reuters ONE [HUG#1738455]